In the ongoing mass tort over the hormone replacement therapy drug Prempro, two small firms recently teamed up to break the defense winning streak in the trials.Read More »
Much like 2009, 2010 was a busy year for prescription drug suits.
Tagged with: Accutane Allergan antidepressant Avandia AztraZeneca Botox Botox litigation Department of Justice DOJ epilepsy failure to warn GlaxoSmithKline heart attack hormone replacement therapy hormone replacement therapy litigation Johnson & Johnson Levaquin Neurontin Paxil Pfizer Premarin Prempro Provera Roche Seroquel WyethRead More »
Consumers must show detrimental reliance in order to hold a drug manufacturer liable for misleading statements in its marketing of hormone replacement therapy drugs, West Virginia’s highest court has ruled.Read More »
Post-menopausal women who take a popular hormone drug combination therapy are at increased risk of getting breast cancer as well as dying from the disease, according to a new federal study.Read More »
With Pfizer and plaintiffs’ lawyers squabbling over who has won the most hormone replacement therapy trials, only one thing about the litigation is clear: it’s turning into one of the longest-running mass torts in U.S. history.Read More »
Negligence claims regarding Redux are not preempted insofar as they relate to the manufacturer’s conduct before the Food and Drug Administration approved the diet drug, the 6th Circuit has ruled in reversing a summary judgment.Read More »